Consistent with its conventional metabolic effects, GOT2 knockdown (KD) in cultured pancreatic cancer cells results in decreased Asp and α-KG production, thereby preventing the normal TCA cycle and decreasing ATP levels. Here, GOT2 is linked to pancreatic neoplasm.